Chemically defined generation of human cardiomyocytes

Cited by (1,001)

Items 601–700 of 1,001

1. Cardiac fibroblast BAG3 regulates TGFBR2 signaling and fibrosis in dilated cardiomyopathy
   Bryan Z. Wang, Margaretha A. J. Morsink, Seong Won Kim, Lori J. Luo, Xiaokan Zhang, Rajesh Kumar Soni, Roberta I. Lock, Jenny Rao, Youngbin Kim, Anran Zhang et al. · 2025 · Journal of Clinical Investigation
2. Atorvastatin Inhibits the HIF1α-PPAR Axis, Which Is Essential for Maintaining the Function of Human Induced Pluripotent Stem Cells
   Yoshiki Nakashima, Chika Miyagi‐Shiohira, Hirofumi Noguchi, Takeshi Ōmasa · 2018 · Molecular Therapy
3. Cardiac Regeneration with Human Pluripotent Stem Cell-Derived Cardiomyocytes
   Misun Park, Young‐sup Yoon · 2018 · Korean Circulation Journal
4. Formation of an electrical coupling between differentiating cardiomyocytes
   М. М. Slotvitsky, V. A. Tsvelaya, A. D. Podgurskaya, Агладзе Константин Игоревич · 2020 · Scientific Reports
5. Generation of Quiescent Cardiac Fibroblasts Derived from Human Induced Pluripotent Stem Cells
   Hao Zhang, Mengcheng Shen, Joseph C. Wu · 2020 · Methods in molecular biology
6. Optimizing the Use of iPSC-CMs for Cardiac Regeneration in Animal Models
   Alexandra Bizy, Matthew Klos · 2020 · Animals
7. Specific induction and long-term maintenance of high purity ventricular cardiomyocytes from human induced pluripotent stem cells
   Hiroyuki Fukushima, Miki Yoshioka, Masahide Kawatou, Víctor López-Dávila, Masafumi Takeda, Yasunari Kanda, Yuko Sekino, Yoshinori Yoshida, Jun K. Yamashita · 2020 · PLoS ONE
8. The role of Sfrp and DKK proteins in cardiomyocyte development
   Ying‐Chang Hsueh, Conrad P. Hodgkinson, Jose A. Gomez · 2021 · Physiological Reports
9. Bioengineering Clinically Relevant Cardiomyocytes and Cardiac Tissues from Pluripotent Stem Cells
   Emma Claire James, Eva Tomaskovic‐Crook, Jeremy Micah Crook · 2021 · International Journal of Molecular Sciences
10. Myosin light chain 2 marks differentiating ventricular cardiomyocytes derived from human embryonic stem cells
    Xiaoling Luo, Peng Zhang, Xiangyuan Liu, Shiqian Huang, Sen-Le Rao, Qiurong Ding, Huang‐Tian Yang · 2021 · Pflügers Archiv - European Journal of Physiology
11. A New Versatile Platform for Assessment of Improved Cardiac Performance in Human-Engineered Heart Tissues
    Marcelo C. Ribeiro, José M. Rivera‐Arbeláez, Carla Cofiño‐Fabrés, Verena Schwach, Rolf H. Slaats, Simone A. ten Den, Kim Vermeul, Albert van den Berg, José María Pérez-Pomares, Loes Irene Segerink et al. · 2022 · Journal of Personalized Medicine
12. Robust, Automated Analysis of Electrophysiology in Induced Pluripotent Stem Cell-Derived Micro-Heart Muscle for Drug Toxicity
    Kasoorelope Oguntuyo, David R. Schuftan, Jingxuan Guo, Daniel W. Simmons, Druv Bhagavan, Jonathan D. Moreno, Po Wei Kang, Evan W. Miller, Jonathan R. Silva, Nathaniel Huebsch · 2022 · Tissue Engineering Part C Methods
13. Challenges and innovation: Disease modeling using human-induced pluripotent stem cell-derived cardiomyocytes
    Louise Reilly, Saba Munawar, Jianhua Zhang, Wendy C. Crone, Lee L. Eckhardt · 2022 · Frontiers in Cardiovascular Medicine
14. Novel cardioprotective mechanism for Empagliflozin in nondiabetic myocardial infarction with acute hyperglycemia.
    Ru-Hua Deng, Kai Jiang, Feng Chen, Yutong Miao, Yan-Qiao Lu, Fang‐Yi Su, Jia-Yi Liang, J. Qian, Dandan Wang, Yao-Zu Xiang et al. · 2022 · Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
15. Diversity of cells and signals in the cardiovascular system
    Eleonora Grandi, Manuel F. Navedo, Jeffrey J. Saucerman, Donald M. Bers, Nipavan Chiamvimonvat, Rose Ellen Dixon, Dobromir Dobrev, Ana Maria Gomez, Osama F. Harraz, Bence Hegyi et al. · 2023 · The Journal of Physiology
16. Fine mapping spatiotemporal mechanisms of genetic variants underlying cardiac traits and disease
    Matteo D’Antonio, Jennifer Nguyen, Timothy D. Arthur, Angelo D. Arias, Timothy D. Arthur, Paola Benaglio, W. Travis Berggren, Victor Borja, Juan Carlos Izpisúa Belmonte, Megan Cook et al. · 2023 · Nature Communications
17. Nutritional requirements of human induced pluripotent stem cells
    Davi M. Lyra‐Leite, Raymond R. Copley, Phillip P. Freeman, Praeploy Pongpamorn, Disheet A. Shah, Donald E. McKenna, Brian Lenny, Emily A. Pinheiro, Carly J. Weddle, Mennat Gharib et al. · 2023 · Stem Cell Reports
18. Modeling Inherited Arrhythmia Disorders Using Induced Pluripotent Stem Cell-Derived Cardiomyocytes
    Vassilios J. Bezzerides, Donghui Zhang, William T. Pu · 2016 · Circulation Journal
19. Drug-Mediated Shortening of Action Potentials in LQTS2 Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes
    Gary Duncan, Karl Firth, Vinoj T. George, Minh Duc Hoang, Andrew Staniforth, Godfrey L. Smith, Chris N. Denning · 2017 · Stem Cells and Development
20. Endogenous IGF Signaling Directs Heterogeneous Mesoderm Differentiation in Human Embryonic Stem Cells
    Yang Yang, Zhili Ren, Faxiang Xu, Ya Meng, Yumeng Zhang, Nana Ai, Yan Long, Hio Ian Fok, Chunhao Deng, Xianyang Zhao et al. · 2019 · Cell Reports
21. RNA Sequencing Analysis of Induced Pluripotent Stem Cell-Derived Cardiomyocytes From Congenital Heart Disease Patients
    Tomoya Kitani, Lei Tian, Tiejun Zhang, Ilanit Itzhaki, Joe Z. Zhang, Ning Ma, Chun Liu, June‐Wha Rhee, Anitra Romfh, George K. Lui et al. · 2020 · Circulation Research
22. Practical adoption of state-of-the-art hiPSC-cardiomyocyte differentiation techniques
    Cassady E. Rupert, Chinedu Irofuala, Kareen L. K. Coulombe · 2020 · PLoS ONE
23. Generating patient-specific induced pluripotent stem cells-derived cardiomyocytes for the treatment of cardiac diseases
    Dorota Jeziorowska, Agathe Korniat, Joe‐Elie Salem, Kenneth Michael Fish, Jean‐Sébastien Hulot · 2015 · Expert Opinion on Biological Therapy
24. Matrix Architecture and Mechanics Regulate Myofibril Organization, Costamere Assembly, and Contractility in Engineered Myocardial Microtissues
    Samuel J. DePalma, Javiera Jilberto, Austin E. Stis, Darcy D. Huang, Jason Lo, Christopher D. Davidson, Aamilah Chowdhury, Robert N. Kent, Maggie E. Jewett, Hiba Kobeissi et al. · 2024 · Advanced Science
25. Human Cardiomyocytes Prior to Birth by Integration-Free Reprogramming of Amniotic Fluid Cells
    Guihua Jiang, Todd J. Herron, Julie Di Bernardo, Kendal A. Walker, K. Sue O’Shea, Shaun Michael Kunisaki · 2016 · Stem Cells Translational Medicine
26. Biomarkers of Human Pluripotent Stem Cell-Derived Cardiac Lineages
    Rhys J.P. Skelton, Timothy J. Kamp, David A. Elliott, Reza Ardehali · 2017 · Trends in Molecular Medicine
27. Muscarinic receptors promote pacemaker fate at the expense of secondary conduction system tissue in zebrafish
    Martina S. Burczyk, Martin D. Burkhalter, Teresa Casar Tena, Laurel A. Grisanti, Michael Kauk, Sabrina Matysik, Cornelia Donow, Monika Kustermann, Melanie Rothe, Yinghong Cui et al. · 2019 · JCI Insight
28. Human Induced Pluripotent Stem Cells Derived from a Cardiac Somatic Source: Insights for an In-Vitro Cardiomyocyte Platform
    Alessandra Maria Lodrini, Lucio Barile, Marcella Rocchetti, Claudia Altomare · 2020 · International Journal of Molecular Sciences
29. Arrhythmogenic risks of stem cell replacement therapy for cardiovascular diseases
    Kang Chen, Yuting Huang, Radhika Rajgopal Singh, Z Wang · 2020 · Journal of Cellular Physiology
30. Human induced pluripotent stem cell-derived cardiomyocytes reveal abnormal TGFβ signaling in type 2 diabetes mellitus
    Ling Fung Paul Tang, Hongkun Wang, Bing Dai, Xiaochen Wang, Danni Zhou, Jiaxi Shen, Fengfeng Guo, Jue Wang, Jing‐Jun Zhou, Hao Wang et al. · 2020 · Journal of Molecular and Cellular Cardiology
31. Ion Channel Expression and Electrophysiology of Singular Human (Primary and Induced Pluripotent Stem Cell-Derived) Cardiomyocytes
    Christina Schmid, Najah Abi‐Gerges, Michael G. Leitner, Dietmar Zellner, Georg F. Rast · 2021 · Cells
32. Single-cell atlas of multilineage cardiac organoids derived from human induced pluripotent stem cells
    Fengzhi Zhang, Hui Qiu, Xiao‐Hui Dong, Xiaoyan Zhang, Chunlan Wang, Xin Li, Xingwu Zhang, Jie Na, Jin Zhou, Changyong Wang · 2022 · Life Medicine
33. Hypoimmunogenic human pluripotent stem cells are valid cell sources for cell therapeutics with normal self-renewal and multilineage differentiation capacity
    Yifan Chen, Yanjie Zhou, Zhongshu Zhou, Yujiang Fang, Lin Ma, Xiaoqing Zhang, Jie Xiong, Ling Liu · 2023 · Stem Cell Research & Therapy
34. p55γ degrades RIP3 via MG53 to suppress ischaemia-induced myocardial necroptosis and mediates cardioprotection of preconditioning
    Zhenyan Li, Rilei Dai, Min Chen, Lixuan Huang, Kun Zhu, Mingyang Li, Wenting Zhu, Yang Li, Ning Xie, Jingchen Li et al. · 2023 · Cardiovascular Research
35. Recent advances in pluripotent stem cell-derived cardiac organoids and heart-on-chip applications for studying anti-cancer drug-induced cardiotoxicity
    Liu, Silin, Fang, Chongkai, Zhong, Chong, Li, Jing, Xiao, Qingzhong · 2023 · Cell Biology and Toxicology
36. Acute Adenoviral Infection Elicits an Arrhythmogenic Substrate Prior to Myocarditis
    Rachel L. Padget, Michael J. Zeitz, Grace A. Blair, Xiaobo Wu, Michael D. North, Mira T. Tanenbaum, Kari E. Stanley, Chelsea M. Phillips, David Ryan King, Samy Lamouille et al. · 2024 · Circulation Research
37. Coordinated Proliferation and Differentiation of Human-Induced Pluripotent Stem Cell-Derived Cardiac Progenitor Cells Depend on Bone Morphogenetic Protein Signaling Regulation by GREMLIN 2
    Jeffery B. Bylund, Linh T. Trinh, Cassandra P. Awgulewitsch, David T. Paik, Christopher S. Jetter, Rajneesh Jha, Jianhua Zhang, Kristof Nolan, Chunhui Xu, Thomas B. Thompson et al. · 2017 · Stem Cells and Development
38. Cardiomyocytes Derived from Human CardiopoieticAmniotic Fluids
    Angela Di Baldassarre, Maria Angela D’Amico, Pascal Izzicupo, Giulia Gaggi, Simone Guarnieri, Maria Addolorata Mariggiò, Ivana Antonucci, Barbara Corneo, Dario Sirabella, Liborio Stuppia et al. · 2018 · Scientific Reports
39. Temporal Impact of Substrate Anisotropy on Differentiating Cardiomyocyte Alignment and Functionality
    Alicia C. B. Allen, Elissa Barone, Nima Momtahan, Cody O. Crosby, Chengyi Tu, Wei Deng, Krista Polansky, Janet Zoldan · 2019 · Tissue Engineering Part A
40. Cardiac Toxicity From Ethanol Exposure in Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes
    Antonio Rampoldi, Monalisa Singh, Qingling Wu, Meixue Duan, Rajneesh Jha, Joshua T. Maxwell, Joshua M. Bradner, Xiaoyu Zhang, Anita P. Saraf, Gary Wright Miller et al. · 2019 · Toxicological Sciences
41. Layer-By-Layer Fabrication of Large and Thick Human Cardiac Muscle Patch Constructs With Superior Electrophysiological Properties
    Daniëlle Pretorius, Asher M. Kahn-Krell, Xi Lou, Vladimir G. Fast, Joel L. Berry, Timothy J. Kamp, Jianyi Jay Zhang · 2021 · Frontiers in Cell and Developmental Biology
42. 3D models of dilated cardiomyopathy: Shaping the chemical, physical and topographical properties of biomaterials to mimic the cardiac extracellular matrix
    Marie Camman, Pierre Joanne, Onnik Agbulut, Christophe Hélary · 2021 · Bioactive Materials
43. Scaffold-based and scaffold-free cardiac constructs for drug testing
    Kenichi Arai, Takahiro Kitsuka, Koichi Nakayama · 2021 · Biofabrication
44. Tissue Engineering and Regenerative Medicine in Basic Research: A Year in Review of 2014
    Jia Huang, Xunxun Lin, Yuan Shi, Wei Liu · 2015 · Tissue Engineering Part B Reviews
45. HOPX-associated molecular programs control cardiomyocyte cell states underpinning cardiac structure and function
    Clayton E. Friedman, Seth W. Cheetham, Sumedha Negi, Richard J. Mills, Masahito Ogawa, Meredith A. Redd, Han Sheng Chiu, Sophie Shen, Yuliangzi Sun, Dalia Mizikovsky et al. · 2023 · Developmental Cell
46. Biophysical, Molecular, and Pharmacological Characterization of Voltage-Dependent Sodium Channels From Induced Pluripotent Stem Cell-Derived Cardiomyocytes
    Adrien Moreau, Aurélie Mercier, Olivier Thériault, Mohamed Boutjdir, Bettina Burger, Dagmar Iris Keller, Mohamed Chahine · 2016 · Canadian Journal of Cardiology
47. Targeted Elimination of Tumorigenic Human Pluripotent Stem Cells Using Suicide-inducing Virus-like Particles
    A. Rampoldi, S. Crooke, M. Preininger, R. Jha, Joshua T. Maxwell, Ling-Mei Ding, P. Spearman, M. G. Finn, Chun-Hui Xu · 2018 · ACS Chemical Biology
48. SORBS2 is a genetic factor contributing to cardiac malformation of 4q deletion syndrome patients
    Fei Liang, Bo Wang, Juan Geng, Guoling You, Jingjing Fa, Min Zhang, Hunying Sun, Huiwen Chen, Qihua Fu, Xiaoqing Zhang et al. · 2021 · eLife
49. Heart in a dish – choosing the rightin vitromodel
    Lika Drakhlis, Robert Zweigerdt · 2023 · Disease Models & Mechanisms
50. Independent compartmentalization of functional, metabolic, and transcriptional maturation of hiPSC-derived cardiomyocytes
    K. Ashley Fetterman, Malorie Blancard, Davi M. Lyra‐Leite, Carlos G. Vanoye, Hananeh Fonoudi, Mariam Jouni, Jean‐Marc DeKeyser, Brian Lenny, Yadav Sapkota, Alfred L. George et al. · 2024 · Cell Reports
51. Strong Elastic Protein Nanosheets Enable the Culture and Differentiation of Induced Pluripotent Stem Cells on Microdroplets
    Elijah Mojares, Clémence Nadal, Daniel Hayler, Hassan Kanso, Alexandra Chrysanthou, Carlos Eduardo Neri-Cruz, Julien E. Gautrot · 2024 · Advanced Materials
52. Cardiac differentiation potential of human induced pluripotent stem cells in a 3D self-assembling peptide scaffold
    Verónica Puig-Sanvicens, Carlos E. Semino, Nicole I. zur Nieden · 2015 · Differentiation
53. Human embryonic stem cell-derived cardiomyocytes as an in vitro model to study cardiac insulin resistance
    Ilvy M. E. Geraets, Dipanjan Chanda, Florence H. J. van Tienen, Arthur van den Wijngaard, Rick Kamps, Dietbert Neumann, Yilin Liu, Jan F. C. Glatz, Joost J.F.P. Luiken, Miranda Nabben · 2017 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
54. Crataegus Extract WS®1442 Stimulates Cardiomyogenesis and Angiogenesis From Stem Cells: A Possible New Pharmacology for Hawthorn?
    Jonas Halver, Kristin Wenzel, Jandirk Sendker, Carmen Carrillo García, Clemens A. J. Erdelmeier, Erik Willems, Mark A. Mercola, Nico Symma, Stephanie Könemann, Egon Koch et al. · 2019 · Frontiers in Pharmacology
55. Mesenchymal Stromal Cells for Sphincter Regeneration: Role of Laminin Isoforms upon Myogenic Differentiation
    Tanja Seeger, Melanie L. Hart, Manuel Elkin Patarroyo, Bernd Rolauffs, Wilhelm K. Aicher, Gerd Klein · 2015 · PLoS ONE
56. Genetic and Tissue Engineering Approaches to Modeling the Mechanics of Human Heart Failure for Drug Discovery
    Michael J. Greenberg, Neil Daily, Ann Wang, Michael K. Conway, Tetsuro Wakatsuki · 2018 · Frontiers in Cardiovascular Medicine
57. Advancing cardiac regeneration through 3D bioprinting: methods, applications, and future directions
    Zilong Zheng, Weijie Tang, Yichen Li, Yinze Ai, Zhi Tu, Jinfu Yang, Chengming Fan · 2023 · Heart Failure Reviews
58. Opportunities and challenges for the use of human samples in translational cardiovascular research: a scientific statement of the ESC Working Group on Cellular Biology of the Heart, the ESC Working Group on Cardiovascular Surgery, the ESC Council on Basic Cardiovascular Science, the ESC Scientists of Tomorrow, the European Association of Percutaneous Cardiovascular Interventions of the ESC, and the Heart Failure Association of the ESC
    Sean M. Davidson, Ioanna Andreadou, Charalambos A. Antoniades, Jozef Bartúnek, Cristina Basso, Bianca J.J.M. Brundel, Robert A Byrne, Gemma Chiva‐Blanch, Paula A. da Costa Martins, Paul Charles Evans et al. · 2025 · Cardiovascular Research
59. The advancement of human pluripotent stem cell-derived therapies into the clinic
    R. Thies, C. Murry · 2015 · Development
60. Novel roles of an intragenic G-quadruplex in controlling microRNA expression and cardiac function
    Min Zhu, Juan Gao, Xianjuan Lin, Yunyun Gong, Y. Qi, Yuanzhen Ma, Yuanxiu Song, Wei Tan, Fangyuan Li, M. Ye et al. · 2021 · Nucleic Acids Research
61. An updated protocol for the cost-effective and weekend-free culture of human induced pluripotent stem cells
    Davi M. Lyra‐Leite, Hananeh Fonoudi, Mennat Gharib, Paul W. Burridge · 2021 · STAR Protocols
62. Optogenetic modulation of cardiac action potential properties may prevent arrhythmogenesis in short and long QT syndromes
    Amit Gruber, Oded Edri, Irit Huber, Gil Arbel, Amira Gepstein, Assad Shiti, Naim Shaheen, Snizhana V. Chorna, Michal Landesberg, Lior Gepstein · 2021 · JCI Insight
63. Environmental Alterations during Embryonic Development: Studying the Impact of Stressors on Pluripotent Stem Cell-Derived Cardiomyocytes
    Federica Lamberto, Irene Peral-Sanchez, Suchitra Muenthaisong, Melinda Zana, Sandrine Willaime‐Morawek, András Dinnyés · 2021 · Genes
64. Microliter Scale Synthesis of Luciferase‐Encapsulated Polymersomes as Artificial Organelles for Optogenetic Modulation of Cardiomyocyte Beating
    Hyemin Kim, Jonathan Yeow, Adrian Najer, Worrapong Kit‐Anan, Richard Wang, Omar Rifaie‐Graham, Chalaisorn Thanapongpibul, Molly M. Stevens · 2022 · Advanced Science
65. Functional Assays Reclassify Suspected Splice-Altering Variants of Uncertain Significance in Mendelian Channelopathies
    Matthew J. O’Neill, Yuko Wada, Lynn D. Hall, Devyn Mitchell, Andrew Michael Glazer, Dan M. Roden · 2022 · Circulation Genomic and Precision Medicine
66. Engineering a conduction-consistent cardiac patch with rGO/PLCL electrospun nanofibrous membranes and human iPSC-derived cardiomyocytes
    Yao Tan, Ying Chen, Tingting Lu, Nevin Witman, Bingqian Yan, Yiqi Gong, Xuefeng Ai, Yang Li, Minglu Liu, Runjiao Luo et al. · 2023 · Frontiers in Bioengineering and Biotechnology
67. RIP140 deficiency enhances cardiac fuel metabolism and protects mice from heart failure
    Tsunehisa Yamamoto, Santosh K. Maurya, Elizabeth Pruzinsky, Kirill Batmanov, Yang Xiao, Sarah M. Sulon, Tomoya Sakamoto, Yang Wang, Ling Lai, Kendra Sierra McDaid et al. · 2023 · Journal of Clinical Investigation
68. Nonsense Variant PRDM16-Q187X Causes Impaired Myocardial Development and TGF-β Signaling Resulting in Noncompaction Cardiomyopathy in Humans and Mice
    Bo Sun, Omid Mohammad Tavakoli‐Rouzbehani, Ryan J. Kramer, Rajeshwary Ghosh, Robin M. Perelli, S. Atkins, Amir Nima Fatahian, Kathryn Davis, Marta W. Szulik, Michael A. Goodman et al. · 2023 · Circulation Heart Failure
69. Medicinal Chemistry Approaches to Heart Regeneration
    Dennis Schade, Alleyn T. Plowright · 2015 · Journal of Medicinal Chemistry
70. Therapeutic Potential of Stem Cells Strategy for Cardiovascular Diseases
    Chang Youn Lee, Ran Kim, Onju Ham, Ji‐Hyun Lee, Pilseog Kim, Seokyeon Lee, Sekyung Oh, Ho‐Jin Lee, Min Young Lee, Jong Min Kim et al. · 2016 · Stem Cells International
71. Partial Reprogramming of Pluripotent Stem Cell-Derived Cardiomyocytes into Neurons
    Wenpo Chuang, Arun Sharma, Praveen Shukla, Guang Li, Moritz Mall, Kuppusamy Rajarajan, Oscar John Abilez, Ryoko Hamaguchi, Joseph C. Wu, Marius Wernig et al. · 2017 · Scientific Reports
72. Efficient generation of transgene- and feeder-free induced pluripotent stem cells from human dental mesenchymal stem cells and their chemically defined differentiation into cardiomyocytes
    Xiaobing Tan, Qingli Dai, Tao Guo, Jingshu Xu, Qingyuan Dai · 2017 · Biochemical and Biophysical Research Communications
73. Quantitative Secretomics Reveals Extrinsic Signals Involved in Human Pluripotent Stem Cell Cardiomyogenesis
    Hanna Wolling, Sarah A. Konze, Anne Höfer, Jelena Erdmann, Andreas Pich, Robert Zweigerdt, Falk F. R. Buettner · 2018 · PROTEOMICS
74. Exploring peptide‐functionalized alginate scaffolds for engineering cardiac tissue from human embryonic stem cell‐derived cardiomyocytes in serum‐free medium
    Dana Hayoun, Nataly Korover, Sharon Etzion, Rivka Ofir, Rachel G. Lichtenstein, Smadar Cohen · 2019 · Polymers for Advanced Technologies
75. Assessing cardiac safety in oncology drug development
    Jonathan H. Seltzer, Gary A. Gintant, Laleh Amiri‐Kordestani, Jack W. Singer, Luana Pesco Koplowitz, Javid J. Moslehi, Ana Barac, Anthony Francis Yu · 2019 · American Heart Journal
76. MIR148A family regulates cardiomyocyte differentiation of human embryonic stem cells by inhibiting the DLL1-mediated NOTCH signaling pathway
    Xing Fang, Shumei Miao, Yu You, Fengyue Ding, Xinglong Han, Hongchun Wu, Zhen‐Ao Zhao, Yongming Wang, Shijun Hu, Wei Lei · 2019 · Journal of Molecular and Cellular Cardiology
77. A Combination of Itraconazole and Amiodarone Is Highly Effective against Trypanosoma cruzi Infection of Human Stem Cell–Derived Cardiomyocytes
    Gabriele Sass, Roy Madigan, Lydia‐Marie Joubert, Adriana Bozzi, Nazish Sayed, Joseph C. Wu, David A. Stevens · 2019 · American Journal of Tropical Medicine and Hygiene
78. A long non‐coding RNA GATA6‐AS1 adjacent to GATA6 is required for cardiomyocyte differentiation from human pluripotent stem cells
    Rajneesh Jha, Dong Li, Qingling Wu, Katherine E. Ferguson, Parvin Forghani, Gregory C. Gibson, Chunhui Xu · 2020 · The FASEB Journal
79. Differentiation and Application of Human Pluripotent Stem Cells Derived Cardiovascular Cells for Treatment of Heart Diseases: Promises and Challenges
    Yu Gao, Jun Pu · 2021 · Frontiers in Cell and Developmental Biology
80. Human BIN1 isoforms grow, maintain, and regenerate excitation–contraction couplons in adult rat and human stem cell-derived cardiomyocytes
    Jia Guo, Xiao Yu Tian, Monika Barth, Wenying Xian, Sandra Ruppenthal, Hans‐Joachim Schaefers, Zhifen Chen, Alessandra Moretti, Karl‐Ludwig Laugwitz, Peter Lipp · 2021 · Cardiovascular Research
81. State-Of-Play for Cellular Therapies in Cardiac Repair and Regeneration
    Venkata Ramana Vaka, Darryl Raymond Davis · 2021 · Stem Cells
82. Large-Scale Production of Cardiomyocytes from Human Pluripotent Stem Cells Using a Highly Reproducible Small Molecule-Based Differentiation Protocol
    Hananeh Fonoudi, Hassan Ansari, Saeed Abbasalizadeh, Gillian M. Blue, Nasser Aghdami, David Scott Winlaw, Richard Paul Harvey, Alexis Bosman, Hossein Baharvand · 2016 · Journal of Visualized Experiments
83. Generation of Heart Organoids Modeling Early Human Cardiac Development Under Defined Conditions
    Yonatan R. Lewis‐Israeli, Mitchell A. Gabalski, Kristen Ball, Aaron H. Wasserman, Jinyun Zou, Guangming Ni, Chao Zhou, Aitor Aguirre · 2020 · SSRN Electronic Journal
84. Cell type and dynamic state govern genetic regulation of gene expression in heterogeneous differentiating cultures
    Joshua M Popp, Katherine Rhodes, Radhika Jangi, Mingyuan Li, Kenneth Barr, Karl Tayeb, Alexis J. Battle, Yoav Gilad · 2024 · Cell Genomics
85. Directed cardiomyogenesis of human pluripotent stem cells by modulating Wnt/β-catenin and BMP signalling with small molecules
    Jose Santiago Aguilar, Aynun Nahar Begum, Jonathan Alvarez, Xiao‐Bing Zhang, Yiling Hong, Jijun Hao · 2015 · Biochemical Journal
86. Bioengineering the Cardiac Conduction System: Advances in Cellular, Gene, and Tissue Engineering for Heart Rhythm Regeneration
    Nataliia Naumova, L. Iop · 2021 · Frontiers in Bioengineering and Biotechnology
87. Chemically defined and small molecules-based generation of sinoatrial node-like cells
    Xiaojie Hou, Shuhong Ma, Wei Fan, Fang Li, Miaomiao Xu, Chao Yang, Feng Liu, Yan Yan, Juyi Wan, Feng Lan et al. · 2022 · Stem Cell Research & Therapy
88. Environmentally relevant exposure to TBBPA and its analogues may not drastically affect human early cardiac development
    Miaomiao Zhao, Nuoya Yin, Renjun Yang, Shichang Li, Shuxian Zhang, Francesco Faiola · 2022 · Environmental Pollution
89. Global Trends of Stem Cell Precision Medicine Research (2018–2022): A Bibliometric Analysis
    Muge Liu, Fan Yang, Yingbin Xu · 2022 · Frontiers in Surgery
90. Fabrication of human myocardium using multidimensional modelling of engineered tissues
    Pilar Montero‐Calle, María Flandes‐Iparraguirre, Konstantinos A. Mountris, A Nava, Nicolás Laita, Ricardo Maximiliano Rosales, Olalla Iglesias‐García, Elena M. De‐Juan‐Pardo, Felipe Atienza, María Eugenia Fernández‐Santos et al. · 2022 · Biofabrication
91. Gene- and variant-specific efficacy of serum/glucocorticoid-regulated kinase 1 inhibition in long QT syndrome types 1 and 2
    Federica Giannetti, Miriam Barbieri, Assad Shiti, Simona Casini, Philip T. Sager, Saumya Das, Sabindra Pradhananga, Dinesh K. Srinivasan, Saranda Nimani, Nicolò Alerni et al. · 2023 · EP Europace
92. Hypertrophy Changes 3D Shape of hiPSC-Cardiomyocytes: Implications for Cellular Maturation in Regenerative Medicine
    Cassady E. Rupert, Heidi H. Chang, Kareen L. K. Coulombe · 2016 · Cellular and Molecular Bioengineering
93. Recreating the Cardiac Microenvironment in Pluripotent Stem Cell Models of Human Physiology and Disease
    Ayhan Atmanli, Ibrahim John Domian · 2016 · Trends in Cell Biology
94. Tissue Engineering of 3D Organotypic Microtissues by Acoustic Assembly
    Yuqing Zhu, Vahid Serpooshan, Sean M. Wu, Utkan Demirci, Pu Chen, Sinan Güven · 2017 · Methods in molecular biology
95. Applying Patient-Specific Induced Pluripotent Stem Cells to Create a Model of Hypertrophic Cardiomyopathy
    Elena Vladimirovna Dementyeva, Sergey P. Medvedev, Victoria Kovalenko, Yuri V. Vyatkin, Evgeny I. Kretov, М. М. Slotvitsky, Dmitry N. Shtokalo, Evgeny A. Pokushalov, Suren M. Zakian · 2019 · Biochemistry (Moscow)
96. A human embryonic stem cell reporter line for monitoring chemical-induced cardiotoxicity
    Su‐Yi Tsai, Zaniar Ghazizadeh, Houjun Wang, Sadaf Amin, Francis A. Ortega, Zohreh Sadat Badieyan, Zi-Ting Hsu, Miriam Gordillo, Ritu Kumar, David J. Christini et al. · 2019 · Cardiovascular Research
97. The resting membrane potential of hSC-CM in a syncytium is more hyperpolarised than that of isolated cells
    Dieter V. Van de Sande, Ivan Kopljar, Maaike Alaerts, Ard C.H. Teisman, David J. Gallacher, Bart Loeys, Dirk J. Snyders, Luc Leybaert, Hua Rong Lu, Alain J. Labro · 2021 · Channels
98. Multiplexing physical stimulation on single human induced pluripotent stem cell-derived cardiomyocytes for phenotype modulation
    Worrapong Kit‐Anan, Manuel M. Mazo, Brian Wang, Vincent Leonardo, Isaac J. Pence, Sahana Gopal, Amy A. Gelmi, Anika Nagelkerke, Michele Becce, Ciro Chiappini et al. · 2021 · Biofabrication
99. Basic Research Approaches to Evaluate Cardiac Arrhythmia in Heart Failure and Beyond
    Max J. Cumberland, Leto Luana Riebel, Ashwin Roy, Christopher O’Shea, Andrew P. Holmes, Chris N. Denning, Paulus F. Kirchhof, Blanca Rodríguez, Katja Gehmlich · 2022 · Frontiers in Physiology
100. A chemically-defined plastic scaffold for the xeno-free production of human pluripotent stem cells
     Eiko Shimizu, Hiroki Iguchi, Minh Nguyen Tuyet Le, Yuta Nakamura, Daigo Kobayashi, Yuhei Arai, Kenta Takakura, Seiko Benno, Noriko Yoshida, Masayoshi Tsukahara et al. · 2022 · Scientific Reports